NeuroPace Investor Relations Material
Latest events
Q4 2023
NeuroPace
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from NeuroPace Inc
Access all reports
NeuroPace, Inc. designs and develops devices to treat patients with refractory epilepsy. The company offers RNS System, a responsive neurostimulator device that is attached to the patient's skull, like a halo, and stimulated their brain with tiny electrical pulses. In addition, its product pipeline comprises RNS Stimulator to replace the traditional battery-powered pacemaker described above with a wireless charger; and rechargeable battery; wireless charger that eliminates the need to physically remove the device from the patient’s head in order to power up the battery; RNS Remote Monitor that enables patients to use an iPad application to indicate when they are having seizures or any other relevant symptoms; and RNS Access Manager that serves as an ingenious monitor for physicians and nurses treating patients. NeuroPace, Inc. was founded in 1997 and is headquartered in Mountain View, California.
Key slides for NeuroPace Inc
Investor Presentation
NeuroPace Inc
Investor Presentation
NeuroPace Inc
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States